PRIA Logo™
MarylandSB 04352026 Regular SessionSenate

Public Health - Medetomidine and Xylazine Consumer Protection Act

Sponsored By: William G. Folden (Republican)

Passed

Public HealthAge -see also- Age of Maj; Children; Elderly; Inf&Tod.; etcComptrollerConsumer ProtectionControlled Dangerous Substances -see also- Drugs; OpioidsDrugs -see also- Cannabis; ControlDangSubst; Pharm; etc.Health -see also- COVID19; EnvHlth; MedCon; etc.Health, Department ofIdentification -see also- Biometrics; Fingerprinting; DrLicsPenalties and Sentences -see also- Death PenaltyRecords -see also- Land Records; Vital RecordsRetail SalesRevenue and Taxes -see also- (specific tax)Rules and RegulationsScientific Research -see also- ChemTst; MedRsrch; StudiesSubstance AbuseVeterinariansWholesale Distribution

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • William G. Folden

    Republican • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Motion Laid Over (Senator Ready) Adopted

    4/13/2026Senate

  2. Favorable with Amendments {983727/1

    4/13/2026Senate

  3. Favorable with Amendments Report by Finance

    4/13/2026Senate

  4. Hearing 2/11 at 2:00 p.m.

    2/3/2026Senate

  5. First Reading Finance

    1/30/2026Senate

Bill Text

  • First Reading

    1/30/2026

    PDF

Related Bills

Back to State Legislation